Avalo Therapeuticsincis A Clinical Stagebiotechnology Company Based In Rockvillemarylandfounded In 2011Thecompany Focuses On Developing Treatments For Immunemediated Inflammatory Diseasesformerly Known As Cerecor Inc Avalo Therapeutics Rebranded In August 2021 Thecompany Is Advancing A Pipelineof Therapeutic Candidatesincluding Its Lead Assetavtx 009A Humanized Monoclonal Antibody Targeting Interleukin 1I Il 1I Which Is Currently In Phase2 Clinical Trialsavalo Also Develops Additional Products Such As Avtx 80 And Avtx 801Aimed At Treating Immunology Related Conditions And Raregenetic Diseasestheir Strategy Is Centered On Addressing Significant Unmet Medical Needs In Theseareas
No conferences found for this company.
| Company Name | Zylera |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.